Reported Oct 12, 2016 · Terminated

Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc.,…

Shire

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Shire · 1200 Morris Dr · Chesterbrook, PA · 19087-5507

Is this the product you have?

  • Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only
  • Manufactured forShire US, Inc., Lexington, MA 02421, NDC 59417-103-10
Lot codes and dates
    • Lot # AF3360B
    • Exp. 04/19
Amount recalled
7,680 bottles (768,000 capsules)

Where it was sold

  • Nationwide

Why it was recalled

Presence of Foreign Tablets/Capsules

This product is unlikely to cause harm, but it breaks a safety or labelling rule.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Shire recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Mar 8, 2019 · Data as of Sep 19, 5:05 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.